Literature DB >> 29043768

Infection of iPSC Lines with Miscarriage-Associated Coxsackievirus and Measles Virus and Teratogenic Rubella Virus as a Model for Viral Impairment of Early Human Embryogenesis.

Denise Hübner1, Kristin Jahn2, Sandra Pinkert3, Janik Böhnke2, Matthias Jung4, Henry Fechner3, Dan Rujescu4, Uwe Gerd Liebert1, Claudia Claus1.   

Abstract

Human induced pluripotent stem cell (iPSC) lines are a promising model for the early phase of human embryonic development. Here, their contribution to the still incompletely understood pathogenesis of congenital virus infections was evaluated. The infection of iPSC lines with miscarriage-associated coxsackievirus B3 (CVB3) and measles virus (MV) was compared to the efficient teratogen rubella virus (RV). While CVB3 and MV were found to be cytopathogenic on iPSC lines, RV replicated without impairment of iPSC colony morphology and integrity. This so far outstanding course of infection enabled maintenance of RV-infected iPSC cultures over several passages and their subsequent differentiation to ectoderm, endoderm, and mesoderm. A modification of the metabolic profile of infected iPSC lines was the only common aspect for all three viruses. This study points toward two important aspects. First, iPSC lines represent a suitable cell culture model for early embryonic virus infection. Second, metabolic activity represents an important means for evaluation of pathogen-associated alterations in iPSC lines.

Entities:  

Keywords:  coxsackievirus; in vitro model for embryogenesis; induced pluripotent stem cells; measles virus; rubella virus

Mesh:

Substances:

Year:  2017        PMID: 29043768     DOI: 10.1021/acsinfecdis.7b00103

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  7 in total

1.  Rubella Viruses Shift Cellular Bioenergetics to a More Oxidative and Glycolytic Phenotype with a Strain-Specific Requirement for Glutamine.

Authors:  Nicole C Bilz; Kristin Jahn; Mechthild Lorenz; Anja Lüdtke; Judith M Hübschen; Henriette Geyer; Annette Mankertz; Denise Hübner; Uwe G Liebert; Claudia Claus
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

2.  Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysis.

Authors:  Zemenu Yohannes Kassa; Siraj Hussen; Solomon Asnake
Journal:  Hum Vaccin Immunother       Date:  2020-03-20       Impact factor: 3.452

3.  Alterations in Cell Mechanics by Actin Cytoskeletal Changes Correlate with Strain-Specific Rubella Virus Phenotypes for Cell Migration and Induction of Apoptosis.

Authors:  Martin Kräter; Jiranuwat Sapudom; Nicole Christin Bilz; Tilo Pompe; Jochen Guck; Claudia Claus
Journal:  Cells       Date:  2018-09-13       Impact factor: 6.600

4.  Influenza a virus-triggered autophagy decreases the pluripotency of human-induced pluripotent stem cells.

Authors:  Ali Zahedi-Amiri; Glen L Sequiera; Sanjiv Dhingra; Kevin M Coombs
Journal:  Cell Death Dis       Date:  2019-04-18       Impact factor: 8.469

5.  Teratogenic Rubella Virus Alters the Endodermal Differentiation Capacity of Human Induced Pluripotent Stem Cells.

Authors:  Nicole C Bilz; Edith Willscher; Hans Binder; Janik Böhnke; Megan L Stanifer; Denise Hübner; Steeve Boulant; Uwe G Liebert; Claudia Claus
Journal:  Cells       Date:  2019-08-10       Impact factor: 6.600

6.  Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression.

Authors:  Janik Böhnke; Sandra Pinkert; Maria Schmidt; Hans Binder; Nicole Christin Bilz; Matthias Jung; Uta Reibetanz; Antje Beling; Dan Rujescu; Claudia Claus
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

7.  Rubella Virus Strain-Associated Differences in the Induction of Oxidative Stress Are Independent of Their Interferon Activation.

Authors:  Sarah Zobel; Mechthild Lorenz; Giada Frascaroli; Janik Böhnke; Nicole C Bilz; Megan L Stanifer; Steeve Boulant; Sandra Bergs; Uwe G Liebert; Claudia Claus
Journal:  Viruses       Date:  2018-10-03       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.